Sriram Venneti

University of Michigan — United States

Medicine · Health Sciences

51h-index10.7kcitations364works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(224), Cancer, Hypoxia, and Metabolism(157), ATP Synthase and ATPases Research(83), Epigenetics and DNA Methylation(45), Mitochondrial Function and Pathology(24)

Publications364 total

Lactylation fuels nucleotide biosynthesis and facilitates deuterium metabolic imaging of tumor proliferation in preclinical models of H3K27M-mutant gliomas
Science Translational Medicine·2026
Diagnostic Utility and Clinicopathologic Associations of Histone H3 Lysine 27 Trimethylation (H3K27me3) Immunohistochemistry for Merkel Cell Carcinoma
Modern Pathology·2025
Digital twins for in vivo metabolic flux estimations in patients with brain cancer
Cell Metabolism·2025Open Access
Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
2025Open Access
Supplementary Information from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
2025Open Access
Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas
Annual Review of Pathology Mechanisms of Disease·2025· 4 cited
CSIG-28. ATRX LOSS LEADS TO H3K4ME3-DRIVEN EPIGENETIC DYSREGULATION OF OLIGODENDROCYTE DIFFERENTIATION AND CELL CYCLE CONTROL IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA (DMG)
Neuro-Oncology·2025Open Access
TMET-04. ZFTA-RELA fusion supratentorial ependymomas enhance glutathione biosynthesis
Neuro-Oncology·2025Open Access
TMET-51. EGFR metabolically suppresses differentiation in H3K27M-mutant diffuse midline glioma
Neuro-Oncology·2025Open Access
TMIC-53. Novel therapy for diffuse midline glioma: Targeting oncohistone drivers with P300/CBP inhibition and Delta-24-RGD
Neuro-Oncology·2025Open Access
TMET-54. Rewiring of cortical glucose metabolism fuels human brain cancer growth
Neuro-Oncology·2025Open Access
EXTH-65. THY1 Mediates Treatment Resistance in H3K7M Pediatric Tumors and is Therapeutically Targetable
Neuro-Oncology·2025Open Access
EXTH-15. Combinatorial targeting of avapritinib-driven MAPK activation in pediatric high-grade glioma
Neuro-Oncology·2025Open Access
TMOD-31. Patient-derived “tumor-oids” recapitulate the tumor microenvironment and allow for pre-clinical drug screening across the entire spectrum of pediatric brain tumors
Neuro-Oncology·2025· 1 citedOpen Access
TMET-21. Lactate metabolism in H3K27M mutant diffuse midline gliomas
Neuro-Oncology·2025Open Access
ANGI-18. DISRUPTING INTEGRIN SIGNALING IMPAIRS MIGRATION, MYC-DRIVEN PURINE BIOSYNTHESIS, AND STEMNESS IN H3K27M DIFFUSE MIDLINE GLIOMAS
Neuro-Oncology·2025Open Access
GABA production induced by imipridones is a targetable and imageable metabolic alteration in diffuse midline gliomas
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025
Rewiring of cortical glucose metabolism fuels human brain cancer growth
Nature·2025· 16 citedOpen Access
Aberrant histone modifications in pediatric brain tumors
Frontiers in Oncology·2025· 1 citedOpen Access
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis
Cancer Cell·2025· 11 cited
page 1 of 19Next →

Frequent Co-authors

Alexander R. Judkins(15), Craig B. Thompson(12), Carl Koschmann(10), Chao Lü(7), Hugh Garton(6), Brian J. Lopresti(6), Clayton A. Wiley(6), Mariarita Santi(6), Daniel Martínez(6), Viveka Nand Yadav(6), Arul M. Chinnaiyan(6), Jason Heth(5), Justin R. Cross(5), Chan Chung(5), Lisa Sullivan(5), Drew Pratt(5), Rajen Mody(5), Sandra Camelo‐Piragua(4), Bruce Pawel(4), Peter W. Lewis(4)